ArticleArthritis care & research2025

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 Trial.

Hermine I Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.